Frontiers in oncology
EQD2-adjusted mean lung dose and symptomatic pneumonitis after thoracic radiotherapy following immune checkpoint inhibitors in lung cancer: a single-center retrospective cohort study
Par Li X, Liu L, Zheng N et 6 autres.
Contenu en anglais
Résumé
Background
Evidence on pneumonitis after thoracic radiotherapy following immune checkpoint inhibitor (ICI) exposure remains limited. We examined associations with voxel-wise EQD2 mean lung dose (MLDEQD2) and the ICI-radiotherapy interval.